Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Rhea-AI Summary

Waters Corporation (NYSE:WAT) said Udit Batra, Ph.D., President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 PM PT (5:15 PM ET).

A live webcast will be available on the company’s Events & Presentations page at https://ir.waters.com, and a replay will be accessible for 90 days. Waters is a global provider of analytical instruments, separations technologies, and software serving life, materials, food, and environmental sciences.

Key Figures

Conference date January 12, 2026 J.P. Morgan Healthcare Conference presentation date

Presentation time PT 2:15 PM Pacific Time Scheduled start time of CEO presentation

Presentation time ET 5:15 PM Eastern Time Equivalent presentation time for Eastern Time zone

Webcast replay window 90 days Length of time replay will be available to investors

Industry experience 65+ years Company history providing analytical instruments and technologies

Employee count 7,600+ employees Global workforce size described in the release

Global reach 100+ countries Number of countries where Waters operates

Conference edition 44th Annual Edition of the J.P. Morgan Healthcare Conference

Market Reality Check

$383.21 Last Close

Volume Volume 464,568 is below the 20-day average of 630,244, suggesting a routine reaction to this conference update. normal

Technical Shares at $384.14 are trading above the 200-day MA of $339.15 and about 9.3% below the 52-week high.

Peers on Argus

Peers in Diagnostics & Research show modest gains, with ILMN up 1.47% and LH up 1.15%, while WAT is up 1.62%, indicating a stock-specific move consistent with, but not driven by, sector action.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 11	Conference appearance	Positive	+2.5%	CEO fireside chat at Jefferies Global Healthcare Conference with webcast access.
Nov 11	Product launch	Positive	+2.5%	Launch of CAD for Empower CDS to reduce LC-CAD communication issues.
Nov 04	Earnings release	Positive	+6.3%	Q3 2025 sales and EPS growth with raised full‑year guidance.
Oct 13	Technology launch	Positive	+1.6%	Launch of Xevo CDMS for high‑mass biomolecule characterization.
Oct 01	Earnings call setup	Positive	+6.7%	Scheduling of Q3 2025 earnings call and webcast for investors.

Pattern Detected

Recent news and earnings items have generally coincided with positive price reactions, including product launches, earnings, and conference participation.

Recent Company History

This announcement continues a series of visibility-building and growth-focused updates for Waters. In October–November 2025, the company scheduled and reported Q3 2025 earnings with higher sales and EPS, launched new analytical technologies, and participated in investor conferences. Those events produced positive single‑day price moves of up to 6.67%. Today’s J.P. Morgan Healthcare Conference appearance fits the pattern of ongoing investor outreach rather than a new financial or product catalyst.

Market Pulse Summary

This announcement details Waters’ upcoming presentation at the J.P. Morgan Healthcare Conference on January 12, 2026, continuing its regular investor outreach. There are no new financial metrics or product updates in this release. In recent months, the company reported stronger Q3 2025 results and launched new technologies, both met with positive share reactions. Investors tracking the story may focus on what incremental information, if any, is shared during the conference webcast.

AI-generated analysis. Not financial advice.

MILFORD, Mass., Dec. 23, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will present at the 44^th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 at 2:15 PM Pacific Time (5:15 PM Eastern Time).

A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.

About Waters Corporation
Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

View original content:https://www.prnewswire.com/news-releases/waters-corporation-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-monday-january-12-2026-302648794.html

SOURCE Waters Corporation

FAQ

When will Waters (WAT) present at the J.P. Morgan Healthcare Conference in 2026?

Waters (WAT) will present on January 12, 2026 at 2:15 PM PT (5:15 PM ET).

Who will represent Waters (WAT) at the January 12, 2026 presentation?

Udit Batra, Ph.D., President and Chief Executive Officer, will present for Waters (WAT).

How can investors watch Waters (WAT) present on January 12, 2026?

A live webcast will be available on Waters’ Events & Presentations page at https://ir.waters.com.

Will there be a replay of the Waters (WAT) JPM presentation and for how long?

Yes. A replay will be available for 90 days after the live webcast.

What topics is Waters (WAT) likely to cover at the J.P. Morgan Healthcare Conference?

The company will discuss recent developments in its analytical instruments, separations technologies, and software businesses.

Where can I find investor contact information for Waters (WAT)?

Investor relations contact is listed via the company’s investor relations site; the press listing includes an investor relations email address.